Boylan James P 4
4 · Immunome Inc. · Filed Jun 12, 2025
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Boylan James P
Director
Transactions
- Award
Director Stock Option (right to buy)
2025-06-10+18,864→ 18,864 totalExercise: $9.57Exp: 2035-06-09→ Common Stock (18,864 underlying)
Footnotes (2)
- [F1]Mr. Boylan has agreed to receive and hold for the benefit of Enavate Sciences, LP, any securities granted to him for his service as a director on the Company's board of directors. As such, Mr. Boylan disclaims beneficial ownership of, and all right, title and interest in, the reported securities.
- [F2]The option vests in four quarterly installments, commencing from June 10, 2025 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to Mr. Boylan's continuous service with the Company on each respective vesting date.